Low bone mineral density in Greek patients with inflammatory bowel disease: Prevalence and risk factors

Annals of Gastroenterology

Volumn 24, Issue 1, 2011, Pages 41-46

  Koutroubakis, Ioannis E ^a   Zavos, Christos ^a   Damilakis, John ^b   Papadakis, Georgios Z ^c   Neratzoulakis, John ^d   Karkavitsas, Nikolaos ^c   Kouroumalis, Elias A ^a  

^a Departments of Gastroenterology   (Greece)

^b Medical Physics   (Greece)

^c Nuclear Medicine   (Greece)

^d UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Bone mineral density; Crohn's disease; Osteocalcin; Ulcerative colitis; Vitamin D

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; 25 HYDROXYVITAMIN D; ADALIMUMAB; AZATHIOPRINE; CALCITONIN; HOMOCYSTEINE; INFLIXIMAB; MESALAZINE; OSTEOCALCIN; SALAZOSULFAPYRIDINE; STEROID;

ADULT; ARTICLE; BODY MASS; BONE DENSITOMETRY; BONE DENSITY; CONTROLLED STUDY; CROHN DISEASE; DISEASE DURATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ENTERITIS; FEMALE; FEMUR NECK; GREECE; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; ULCERATIVE COLITIS; VITAMIN BLOOD LEVEL;

EID: 79952029454     PISSN: 11087471     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 1994; 4:368-381.
2. Bernstein CN. Osteoporosis in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2006; 4:152-156.
3. Lichtenstein GR, Sands BE, Pazianas M. Prevention and treatment of osteoporosis in inflammatory bowel disease. Inflamm Bowel Dis 2006; 12:797-813.
4. Tilg H, Moschen AR, Kaser A, et al. Gut, inflammation and osteoporosis: basic and clinical concepts. Gut 2008; 57:684-694.
5. Semeao EJ, Jawad AF, Stouffer NO, Zemel BS, Picaoli DA, Stallings VA. Risk factors for low bone mineral density in children and young adults with Crohn's disease. J Pediatr 1999; 135:593-600.
6. Siffledeen JS, Fedorak RN, Siminoski K, et al. Bones and Crohn's: risk factors associated with low bone mineral density in patients with Crohn's disease. Inflamm Bowel Dis 2004; 10:220-228.
7. Ghosh S, Cowen S, Hannan WJ, Ferguson A. Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. Gastroenterology 1994; 107:1031-1039.
8. Bjarnason I, Macpherson A, Mackintosh C, Buxton-Thomas M, Forgacs I, Moniz C. Reduced bone density in patients with inflammatory bowel disease. Gut 1997; 40:228-233.
9. Turk N, Cukovic-Cavka S, Korsic M, Turk Z, Vucelic B. Proinflammatory cytokines and receptor activator of nuclear factor kappaB-ligand/osteoprotegerin associated with bone deterioration in patients with Crohn's disease. Eur J Gastroenterol Hepatol 2009; 21:159-166.
10. Gilman J, Shanahan F, Cashman KD. Altered levels of biochemical indices of bone turnover and bone-related vitamins in patients with Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther 2006; 23:1007-1016
11. McCarthy D, Duggan P, O'Brien M, et al. Seasonality of vitamin D status and bone turnover in patients with Crohn's disease. Aliment Pharmacol Ther 2005; 21:1073-1083.
12. Roblin X, Phelip JM, Genevois M, Ducros V, Bonaz B. Hyperhomocysteinaemia is associated with osteoporosis in patients with Crohn's disease. Aliment Pharmacol Ther 2007;25:797-804.
13. Stange EF, Travis SPL, Geboes K, et al, for the European Crohn's and Colitis Organisation (ECCO). European Consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohn's Colitis 2008;2:1-23.
14. Stange EF, Travis SPL, Vermeire S, et al. European Crohn's and Colitis Organisation. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 2006;55:1-15.
15. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005;19 Suppl A:5-36.
16. Katsanos KH, Tsianos EV. From Vienna to Montreal: the new Crohn's disease classification. Ann Gastroenterol 2006;19:143-144
17. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70:439-444
18. Walmsley RS, Ayres RC, Pounder RE, et al. A simple clinical colitis activity index. Gut 1998;43:29-32
19. Ardizzone S, Bollani S, Bettica P, Bevilacqua M, Molteni P, Bianchi Porro G. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis. J Intern Med 2000; 247:63-70.
20. Frei P, Fried M, Hungerbuhler V, Rammert C, Rousson V, Kullak-Ublick GA. Analysis of risk factors for low bone mineral density in inflammatory bowel disease. Digestion 2006;73:40-46.
21. Bartram SA, Peaston RT, Rawlings DJ, Walshaw D, Francis RM, Thompson NP. Mutifactorial analysis of risk factors for reduced bone mineral density in patients with Crohn's disease. World J Gastroenterol 2006;12:5680-5686.
22. Walther F, Fusch C, Radke M, Beckert S, Findeisen A. Osteoporosis in pediatric patients suffering from chronic inflammatory bowel disease with and without steroid treatment. J Pediatr Gastroenterol Nutr 2006;43:42-51.
23. Sakellariou GT, Moschos J, Berberidis C, et al. Bone density in young males with recently diagnosed inflammatory bowel disease. Joint Bone Spine 2006;73:725-728.
24. Dear KL, Compston JE, Hunter JO. Treatments for Crohn's disease that minimise steroid doses are associated with a reduced risk of osteoporosis. Clin Nutr 2001;20:541-546.
25. Jahnsen J, Falch JA, Mowinckel P, Aadland E. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol 2002;37:192-129.
26. Tsironi E, Hadjidakis D, Mallas E, Tzathas C, Karamanolis DG, Ladas SD. Comparison of T- and Z-score in identifying risk factors of osteoporosis in inflammatory bowel disease patients. J Musculoskelet Neuronal Interact 2008;8:79-84.
27. Koutroubakis IE, Dilaveraki E, Vlachonikolis IG, et al. Hyperhomocysteinemia in Greek patients with Inflammatory Bowel Disease. Dig Dis Sci 2000;45:2347-2351.
28. Leslie WD, Miller N, Rogala L, et al. Body mass and composition affect bone density in recently diagnosed inflammatory bowel disease: the Manitoba IBD Cohort Study. Inflamm Bowel Dis 2009;15:39-46.
29. Lee N, Radford-Smith GL, Forwood M, et al. Body composition and muscle strength as predictors of bone mineral density in Crohn's disease. J Bone Miner Metab 2009; 27:456-463.
30. Rosen CJ, Klibanski A. Bone, fat, and body composition: evolving concepts in the pathogenesis of osteoporosis. Am J Med 2009;122:409-414.
31. Koutroubakis IE, Zavos C, Damilakis J, et al. Role of ghrelin and insulin-like growth factor binding protein-3 in the development of osteoporosis in inflammatory bowel disease. J Clin Gastroenterol [In press].